Trial intelligence / Profile preview

Cognitive state monitoring before and after single-dose zolpidem in healthy volunteers

2007-001688-31Phase 2Active

Sponsor
Larimar Therapeutics
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of zolpidem in Insomnia (2 arms), sponsored by Larimar Therapeutics. Primary endpoints: Night 63-lead EEG recording and Night polysomnographic recording. Started Apr 2007; status: active.

02

Drugs

zolpidem
03

Conditions

Insomnia

Beyond the preview

Go deeper on 2007-001688-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001688-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call